Metavention
company
About
Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases.
- Eden Prairie,Minnesota,United States
- 1 - 10
- http://www.metavention.com
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $65M
- Industries
- Biotechnology,Diabetes,Health Care
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Metavention, Inc.
Metavention develops new treatment that is intended to permanently disrupt the overactive nerves that cause high blood pressure and other metabolic diseases. They offer a renal denervation procedure that delivers radio frequency energy to targeted overactive sympathetic nerves using their IRF denervation system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$65M
Metavention has raised a total of
$65M
in funding over 2 rounds. Their latest funding was raised on
Jan 8, 2018 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 8, 2018 | Series C | $65M | 5 |
New Enterprise Associates
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
Metavention is funded by 5 investors.
New Enterprise Associates
and RK Mellon
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
New Enterprise Associates
|
Yes | Series C |
|
|
— | Series C |
|
|
— | Series C |
Sanderling Ventures
|
— | Series C |
Versant Ventures
|
— | Series C |
Employee Profiles
Number of Employee Profiles
5
Metavention has 5 current employee profiles, including
Board member Kevin Hykes
Board member
Board member
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
